Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

May 1, 2014

Primary Completion Date

June 29, 2023

Study Completion Date

June 29, 2023

Conditions
Patients Transplanted With NiCord/CordIn (Omidubicel)
Interventions
GENETIC

NiCord®/CordIn™ (omidubicel)

Trial Locations (10)

27705

Duke University Medical Center, Durham

27710

Duke University Medical Center, Durham

37240

Vanderbilt, Nashville

46009

Hospital Universitario La Fe, Valencia

60153

Loyola University, Cardinal Bernardin Cancer Center, Maywood

94609

UCSF Benioff Children's Hospital, Oakland

119074

National University Cancer Institute, Singapore

169608

Singapore General Hospital, Singapore

3503 AB

University Medical Center Utrecht, Utrecht

08035

University Hospital Vall D'Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gamida Cell ltd

INDUSTRY